PRESS RELEASE TiGenix confirms strategic focus on Cx601 and its adipose derived stem cell eASC platform Leuven BELGIUM December 20 2017 700h CET TiGenix NV Euronext Brussels and NASDAQ TIG "TiGenix" or "the Company&qu...
↧